Business · 07/10/2026
Manning & Napier Fund, Inc., et al.
Automatycznie zebrany komunikat ze źródła.
Source: Federal Register — SECOpen original release →
LATEST SIGNALS
6Business · 10/17/2026
Navan Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Navan, Inc.
Law firm Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., has launched an investigation into Navan, Inc.'s officers and directors following a notice from the company.
Read summary →Business · 10/17/2026
Brightmoor Hospice, LLC Data Security Incident Notification
Brightmoor Hospice, LLC is notifying patients that a data security incident may have compromised certain protected health information, which occurred around March 2026.
Read summary →Business · 10/17/2026
Paris Court Ruling on Discontinued Function to Have Minimal Impact on Angelalign Customers
Angelalign Technology Inc. has replaced its 'Torque Ridges' with improved 'Pressure Points' in Europe, with a recent Paris court ruling having minimal effects on the company's customers.
Read summary →Business · 10/17/2026
EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
EVIDENT has introduced a new benchtop scanner, Pramana POD, which enables laboratories to create high-quality whole slide images with minimal operator involvement, aiming to support small and medium-sized labs in their digital pathology journey.
Read summary →Business · 10/17/2026
EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
EVIDENT has introduced a new benchtop scanner, Pramana POD, to enable small and medium-sized labs to create high-quality whole slide images with minimal operator involvement, leveraging autonomous imaging technology.
Read summary →Business · 10/16/2026
Fox Factory Holding Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Fox Factory Holding (FOXF)
Fox Factory Holding has received a notice from Levi & Korsinsky regarding a pending investigation into the company, following a revision of its FY2026 guidance in May and August, citing weaker Marucci performance and supply chain disruptions.
Read summary →